Cargando…

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma

BACKGROUND: Targeted therapies have substantially improved survival in cancer patients with malignancies outside the brain. Whether in-depth analysis for molecular alterations may also offer therapeutic avenues in primary brain tumors remains unclear. We herein present our institutional experience f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blobner, Jens, Dengler, Laura, Blobner, Sven, Eberle, Constantin, Weller, Jonathan, Teske, Nico, Karschnia, Philipp, Rühlmann, Katharina, Heinrich, Kathrin, Ziemann, Frank, Greif, Philipp A, Jeremias, Irmela, Wuerstlein, Rachel, Hasselmann, Korbinian, Dorostkar, Mario, Harter, Patrick N, Quach, Stefanie, Stoecklein, Veit, Albert, Nathalie L, Niyazi, Maximilian, Tonn, Joerg-Christian, Thon, Niklas, Christoph Westphalen, Benedikt, von Baumgarten, Louisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243988/ https://www.ncbi.nlm.nih.gov/pubmed/37287694 http://dx.doi.org/10.1093/noajnl/vdad060

Ejemplares similares

Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers
por: Karschnia, Philipp, et al.
Publicado: (2021)

Shunt dependency in supratentorial intraventricular tumors depends on the extent of tumor resection
por: Teske, Nico, et al.
Publicado: (2023)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?
por: Teske, Nico, et al.
Publicado: (2021)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
por: Teske, Nico, et al.
Publicado: (2023)

Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
por: Weller, Jonathan, et al.
Publicado: (2022)

In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer
por: Zhang, Wenlong, et al.
Publicado: (2021)

Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome
por: Teske, Nico, et al.
Publicado: (2022)

Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
por: Weller, Jonathan, et al.
Publicado: (2023)

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
por: Karschnia, Philipp, et al.
Publicado: (2022)

Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board
por: Heinrich, Kathrin, et al.
Publicado: (2022)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022)

PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression
por: Weller, Jonathan, et al.
Publicado: (2021)

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer
por: Xu, Tao, et al.
Publicado: (2023)

Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
por: Katzendobler, Sophie, et al.
Publicado: (2022)

The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
por: Siller, Sebastian, et al.
Publicado: (2021)

Functional connectivity MRI provides an imaging correlate for chimeric antigen receptor T-cell-associated neurotoxicity
por: Stoecklein, Sophia, et al.
Publicado: (2023)

Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells
por: Karschnia, Philipp, et al.
Publicado: (2021)

Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
por: Quach, Stefanie, et al.
Publicado: (2022)

SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine
por: Karschnia, Philipp, et al.
Publicado: (2021)

Mutational signature of extracranial meningioma metastases and their respective primary tumors
por: Biczok, A., et al.
Publicado: (2023)

Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
por: Dorostkar, Mario M, et al.
Publicado: (2022)

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment
por: Schoeberl, Florian, et al.
Publicado: (2022)

Clustering of critically ill patients using an individualized learning approach enables dose optimization of mobilization in the ICU
por: Fuest, Kristina E., et al.
Publicado: (2023)

Managing admission and discharge processes in intensive care units
por: Bai, Jie, et al.
Publicado: (2021)

Acute Retinal Necrosis: Signs, Treatment, Complications and Outcome
por: Mayer, Christian S., et al.
Publicado: (2022)

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
por: Bartos, Laura M., et al.
Publicado: (2022)

Postoperative [(68)Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1
por: Teske, Nico, et al.
Publicado: (2023)

Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
por: Sultova, Elena, et al.
Publicado: (2021)

Self-Reported, Structured Measures of Recovery to Detect Postoperative Morbidity
por: Anetsberger, Aida, et al.
Publicado: (2015)

Influence of the acuity of patients’ illness on effectiveness of early, goal-directed mobilization in the intensive care unit: a post hoc analysis
por: Scheffenbichler, Ludwig, et al.
Publicado: (2020)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
por: Sultova, Elena, et al.
Publicado: (2020)

Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade I
por: Biczok, Annamaria, et al.
Publicado: (2021)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
por: Karschnia, Philipp, et al.
Publicado: (2022)

Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012)

Algorithm-guided goal-directed haemodynamic therapy does not improve renal function after major abdominal surgery compared to good standard clinical care: a prospective randomised trial
por: Schmid, Sebastian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_08n3rjfcn0mbfmma0kb9jtug6o